<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184430</url>
  </required_header>
  <id_info>
    <org_study_id>Algebra</org_study_id>
    <nct_id>NCT01184430</nct_id>
  </id_info>
  <brief_title>Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery</brief_title>
  <acronym>Algebra</acronym>
  <official_title>Monocentric Pilot Study of Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery patients have a high risk to suffer from postoperative infections. Some
      studies have shown, that humoral and cellular factors are associated with perioperative
      immunodysfunction and can increase the risk of postoperative infections. Monocytes in the
      blood and, especially alveolar macrophages are important for an adequate host defence. In
      studies the investigators have shown that hemodynamic parameters have a significant influence
      on the probability to develop postoperative infections. The aim of the study is to
      investigate, whether cardiac surgery patients have an altered immune function after surgery
      that is predictive for the latter development of subsequent infections and whether they
      benefit from a goal-directed volume and hemodynamic therapy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HLA-DR Expression on monocytes after surgery</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Postoperative Wound Infection</condition>
  <condition>Postoperative Outcome</condition>
  <arm_group>
    <arm_group_label>advanced hemodynamic monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>advanced hemodynamic monitoring with pulse contour analysis ( LiDCO rapid) and goal-directed therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard monitoring</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>hemodynamic monitoring based on the standard operating procedures of our clinic</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulse contour cardiac output device</intervention_name>
    <description>Goal directed volume therapy using stroke volume variation and cardiac output to guide volume therapy and inotropic support.</description>
    <arm_group_label>advanced hemodynamic monitoring</arm_group_label>
    <other_name>Non calibrated pulse contour cardiac output monitor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cardiac surgery patient undergoing cardiopulmonary bypass

          -  signed informed consent

        Exclusion Criteria:

          -  pregnant or breast feeding women

          -  Age &lt;18 years

          -  pulmonary disease with an oxygenation index &lt;300mmHg

          -  liver disease (&gt;Child B)

          -  HIV-Infection

          -  Therapy with corticosteroids

          -  Condition after transplantation

          -  preexisting infection before operation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Sander, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Anesthesiology Charité Universitaetsmedizin Berlin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudia Spies, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anesthesiology Charité Universitaetsmedizin Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Sander, MD</last_name>
    <phone>+49 30 450 531</phone>
    <phone_ext>012</phone_ext>
    <email>Michael.Sander@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katharina Berger, MD</last_name>
    <phone>+49 30 450 531</phone>
    <phone_ext>052</phone_ext>
    <email>Katharina.Berger@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Sander, MD</last_name>
      <phone>+4930 450 531</phone>
      <phone_ext>052</phone_ext>
      <email>Michael.Sander@charite.de</email>
    </contact>
    <investigator>
      <last_name>Michael Sander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>August 8, 2013</last_update_submitted>
  <last_update_submitted_qc>August 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Michael Sander</investigator_full_name>
    <investigator_title>Vice Chair</investigator_title>
  </responsible_party>
  <keyword>advanced hemodynamic monitoring</keyword>
  <keyword>goal-directed therapy</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>hemodynamic monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

